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Abstract
Objective: Helicobacter Pylori (H.P) is a common bacterial infection that has been associated with 
diabetes mellitus (DM). The aim of the study was to determine the prevalence of Helicobacter pylori 
infection in patients with DM and the association with anthropometry, duration of DM and medication. 
Method: A cross sectional study involving consecutive recruitment of 193 subjects; 99 diabetics 
attending the outpatient clinic and 94 controls from hospital staffs. The Heliprobe urea breath test was 
used in the detection of H.P. 
2Results:  The prevalence of H.P was 96.8% in the controls and 85.6% in the diabetics (X  =7.56, P =0.006) 
2 
with significant female preponderance among the diabetics (X =7.01, P=0.008). H.P had no significant 
association among the diabetics with regards to BMI, duration of DM and medication.  
Conclusion: The prevalence of Helicobacter pylori was higher in the control than the diabetics.
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Prévalence de Helicobacter pylori chez des patients diabétiques dans 
un hôpital tertiaire du sud-ouest du Nigéria.
Resume
Objectif: Helicobacter Pylori (H.P) est une infection bactérienne commune associée au diabète 
sucré. Le but de cette étude était de déterminer la prévalence de l'infection à Helicobacter pylori 
chez les patients atteints de diabète et l'association avec l'anthropométrie, la durée du diabète et la 
médication.
Méthode: Une étude transversale impliquant le recrutement consécutif de 193 sujets; 99 
diabétiques fréquentant la clinique externe et 94 témoins du personnel hospitalier. Le test 
respiratoire à l'urée Heliprobe a été utilisé pour la détection de l'HP.
Résultats: La prévalence de l'HP était de 96,8% chez les témoins et de 85,6% chez les 
diabétiques ( =7,56, P=0,006) avec une prépondérance féminine importante chez les 
diabétiques ( =7,01, P = 0,008). H.P n'avait pas d'association significative parmi les diabétiques 
en ce qui concerne l'IMC, la durée du diabète et les médicaments.
Conclusion: la prévalence d'Helicobacter pylori était plus élevée chez les témoins que chez les 
diabétiques.
Mots clés: Helicobacter pylori, diabète sucré, hôpital tertiaire
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Hospital setting: Olabisi Onabanjo University 
Teaching Hospital is 205 bedded hospitals 
situated in Ogun State (Sagamu). She is located in 
the south western part of Nigeria and receives 
referrals from both public and private hospitals 
from Lagos metropolitan and the communities 
around Sagamu for both inpatient and outpatient 
care.
Procedure
This single point study involved   
consenting consecutive Type 2 DM patients and 
similar age and sex matched healthy controls. 
The inclusion criteria for the controls was for 
their fasting blood drawn to meet the WHO 
criteria of FBG <7.1mmol/L. For all subjects, 
they were excluded if there was a history of peptic 
ulcer disease, intake of antibiotics, proton pump 
inhibitors, H2 receptor blockers, or antacids in 
the last 4 weeks, past and present evidence of 
active gastrointestinal bleeding, jaundice and 
symptoms of upper astrointestinal disease such as 
indigestion, nausea, vomiting and epigastric 
burning pain. A well-structured pretested 
questionnaire was administered by a medical 
doctor to each participant. The questionnaire 
included bio data, anthropometry, socioeconomic 
variables such as occupation and level of 
education, prior knowledge of diabetic status, 
duration of diabetes and the medication they were 
on. The indigenous language of the people in 
Ogun state is Yoruba although the questionnaire 
was in English. When needed, translation was 
done. Informed consent was obtained from the 
patients after the purpose of the study was 
explained to them with anonymity assured. 
Screening of H. pylori status was done with the 
Urea breath testing (UBT) which is currently 
considered to be the gold standard for non-
invasive diagnosis of Helicobacter pylori 
infection; the Heliprobe® System has been 
validated and found to be comparable to 
conventional UBT, with the advantage of being a 
diagnostic system for detection of H. pylori 
directly in the doctor's office. Results are 
expressed as 0= patient not infected (negative), 
2= patient infected (positive), 1= borderline.  
Ethical approval was obtained from the Ethics 
Committee of the Hospital before the study 
commenced.
Statistical package for social science 
(SPSS) version 20 was used for data analysis. The 
univariate analysis was performed by descriptive 
statistics through frequencies and percentages. 
Categorical variables were expressed as 
frequency (%), and group comparison were by 
INTRODUCTION
Helicobacter Pylori (H. Pylori) is a 
common bacterial infection and has been 
recognized as a worldwide public health 
problem. Over 50% of the world's populations 
have been infected with the bacteria and the 
developing countries having the highest 
prevalence rate (1). It is the cause of several 
gastrointestinal diseases and non-gastrointestinal 
complication. Type 2 Diabetes mellitus is an 
emerging pandemic responsible for an estimated 
  3.8 million adult deaths worldwide (2). There is 
growing evidence to suggest that H. Pylori may 
play a role in diabetes as H. Pylori  infection has 
been associated with increased levels of C-
reactive protein (CRP) and interleukin 6 (IL 
6)and subsequently insulin resistance which has 
been epidemiologically linked to type 2 diabetes 
mellitus (3). Diabetes mellitus makes a patient 
more susceptible to infection and gastroparesis 
diabeticorum which may lead to bacterial 
overgrowth in the upper gastrointestinal tract (4). 
Also infection with Helicobacter pylori induces 
gastric inflammation leading to increase in 
cytokines, which could be deleterious for the 
control of the blood glucose in diabetics.(4). The 
prevalence of Helicobacter pylori colonization 
among diabetics as reported in world literature 
varies between 37% and 85%. (5, 6). Although 
the findings of various studies are inconsistent, 
the presence of H. pylori is found to be higher in 
diabetic patients compared with non-diabetic 
patients (7-9). There is paucity of data on H. 
Pylori in Diabetes mellitus in Nigeria hence the 
need for this study. This study determined the 
prevalence rate of H. Pylori in patients with Type 
2 Diabetes Mellitus as against non-diabetics and 
any association with relevant clinical parameters.
MATERIALS AND METHODS
Study design
This was a cross-sectional study in which 
patients with type 2 Diabetes attending the 
Endocrine and metabolic clinic of the Olabisi 
Onabanjo University Teaching Hospital were 
consecutively recruited; similarly age and sex 
matched healthy consenting controls were also 
recruited consecutively among the hospital 
workers. Helicobacter pylori screening was done 
using the urea breath test. The sample size was 
calculated using the Cochran's formula N= 
2 2
Z pq/d  where Z= Standard normal deviate set at 
1.96, p= set at 13%, q= (1-p) d= is the acceptable 
margin of error set at 0.05. This gave a Sample 
size of 173, attrition of twenty was added and 
sample size became 193.
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was 96.8% in non-diabetics and 85.6% in 
diabetics (p<0.05). This contrasts a study by 
Oluyemi et al in Nigeria who reported 
significantly lower prevalence in the diabetics 
and the control group of 18% and 13% 
respectively (10). Furthermore the findings of 
studies on the prevalence of H. Pylori in diabetes 
mellitus patients have been contradictory; some 
studies found that H. pylori infection was 
significantly higher in the DM group compared to 
the control group (11, 12) while some studies did 
not find any significant difference in the DM 
group and the control group with regard to H. 
pylori infections (13, 14). This study showed a 
higher prevalence of H. Pylori in the control 
group. Although the finding in this study seems to 
be at contrast to either studies in which 
Helicobacter Pylori was more prevalent in 
diabetes than control group or showed no 
differences; generally the literature have reported 
that H. Pylori has a high prevalence in Africa as 
the infection is acquired in childhood. (15, 16) In 
fact in most under developed countries an 
endemic of Helicobacter pylori goes unchecked 
and most adults are infected (4, 17).
Among the males and females, it was 
observed that the females had higher prevalence 
of Helicobacter Pylori in both the non- diabetics 
(98.3%) and the diabetics (93.3%) however the 
female preponderance was significant (P<0.05) 
among the diabetics. This apparently suggests a 
female predilection for the infection. Other 
documented studies however have showed a 
male preponderance in both in the diabetics and 
control groups (4, 18, 19), although Shahram et 
al, demonstrated that the female were 
significantly more positive for H. Pylori in the 
study done albeit among patients with gastric 
tumor (20). The reason for this female 
preponderance in this study is unclear. 
 In relation to age, the prevalence of the 
Helicobacter Pylori positivity was found to be 
higher among the age-group 20-40 years in both 
the non-diabetics (100%) and in the diabetic 
group (100%), however though there was no 
statistical significance when compared with the 
other age groups. The plausible reason might be 
because the infection is acquire in childhood and 
may persist till an older age especially if left 
unchecked. Among the diabetics, the prevalence 
of H. Pylori in underweight was higher when 
compared with the other categories however it 
was not significant which is in contrast with 
reported study where H.Pylori has been 
associated with overweight and obesity. (21) 
When considering the medications the diabetics 
the Pearson's Chi-square. Student t test was used 
for Intergroup mean comparison. A p< 0.05 was 
used as cut off level for statistical significance. 
.
RESULTS
A total of 193 participants' were 
recruited. There were 99 (51.3%) diabetics and 
94 (48.7) non-diabetics. The mean age of all the 
subjects was 60.0±12.3 years and the modal age 
g r o u p  w a s  4 1 - 6 0 y e a r s .  T h e r e  w e r e  
predominantly female, 118 (61.1%) with a 
female to male ratio of 1.6:1 Tertiary education 
was obtained by 33.2% of the subjects. See table 
1  
Helicobacter pylori was positive in 85 
(85.9%) of diabetics and 91 (96.8%) of non-
2
diabetics(X =7.197, p=0.007.).The overall 
prevalence of Helicobacter Pylori among all the 
subjects was 176(91.2%).  Overall, more 
females, 113 (95.8%) were positive for 
Helicobacter Pylori when compared with the 
males (84.0%) which was statistically significant 
2(X =7.899, p=0.005). Among the diabetics 
population, more females (93.3%) were 
statistically positive for H. Pylori compared with 
2the males (74.4%) (X =7.009, p=0.008); whereas 
among the non-diabetics the difference in 
positivity across the gender was not significant. 
Helicobacter Pylori positivity across the three 
age groups showed a higher positivity across the 
age group 20-40 years in both the diabetics and 
non-diabetics however it was not significant.  
With regards to body mass index, there was no 
significant association across all categories as 
regards to positivity to H.P among both the 
diabetic and the non-diabetes. See Table 2 and 3. 
Among those positive for H. Pylori among the 
diabetics, there was no statistical difference when 
the medications they were on were compared. 
The underweight diabetics appeared to be more 
positive for H. Pylori when compared with the 
other categories however it was not significant. It 
was also observed that there was no significant 
association between the presence of H.Pylori and 
the duration of diabetes. See Table 3
DISCUSSION
Helicobacter pylorus is a common 
bacterial infection which has been implicated to 
cause gastrointestinal and non-gastrointestinal 
related disorders. Patients with diabetes mellitus 
are susceptible to infection and gastroparesis 
diabeticorum which may lead to bacterial 
overgrowth in upper gastro-intestinal tract hence 
the need for this study to identify at risk group. In 
this study, the prevalence of Helicobacter pylorus 
Prevalence of helicobacter pylori in diabetes patient at a tertiary hospital            Adeleye et al.
Res. J. of Health Sci. Vol 7(2), April/June 2019                                                        166
Grobbee DE, Neal B. The global burden of 
diabetes and its complication: an emerging 
pandemic. Eur J Cardiovasc Prev Rehaabil.  
2010; 17 (Suppl 1): S3-S8.
3. Nabipour I, Vahdat k, Jafari SM, Pazoki R, 
Sanjdideh Z. The association of metabolic 
syndrome and Clamydia Pneumoniae,  
Helicobacter Pylori, Cytomegalovirus, and 
herpes Simplex virus type 1: The Persian Gulf 
Healthy Heart Study. Cardiovasc Diabetol. 2006; 
5: 25.
4. Khwaja SZ, Vidyasagar R, Manoj K. A study of 
Helicobacter pylori infection in diabetes mellitus. 
Int J Res Med Sci. 2016; 4(9):4166-4171.
5. Hurtado A, Owen RJ. A rapid identification 
scheme for Helicobacter pylori and other species 
of helicobacter based on 23 S rRNA gene 
polymorphism. System Appl. Microbiol. 1997; 
20: 222-31. 
6. 6.  Miah MA, Rahman MT, Hasan M, Khan AK. 
Sero prevalence of Helicobacter pylori among 
the diabetic population in Bangladesh: A 
comparative serological study on the newly 
diagnosed and older diabetics. Bangladesh Med 
Res Counc Bull.  2001; 27(1):9-18.  .
7. Devrajani BR, Shah SZA, Soomro AA, Devrajani 
T. “Type 2 diabetes mellitus: a risk factor for 
Helicobacter pylori infection: a hospital based 
case-control study,” Int J Diabetes Dev Ctries. 
2010; 30(1):22–26. 
were on and duration of diabetes in relation with 
H.Pylori positivity, no significant differences 
was observed. These findings are comparable to 
another study done (4).
CONCLUSION
Helicobacter pylori infection is more 
prevalent in non-diabetics than in diabetics and 
there was a female predilection in all the study 
population, significantly more among the 
diabetics. Among the diabetic population there 
was no significant association with body mass 
index, and the medication they were on.
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X2/t P value 
Age group     
20-40 (n=11) 4(36.4) 7(63.6)   
41-60 (n=97) 50(51.5) 47(48.5) 1.660 0.436 
61-80 (n=78) 44(56.4) 34(43.6)   
Mean age 60.7±12.0 58.4±12.6 1.281 0.202 
Sex     
Males (n=75) 39(52.0) 36(48.0) 0.024 0.876 
Females (n=118) 60(50.8) 58(49.2)   
Educational 
Background 
    
None (n=25) 16(64) 9(36.0)   
Primary (n=42) 22(52.4) 20(47.6) 3.702 0.295 
Secondary (n=53) 25(47.2) 28(52.8)   
Tertiary (n=64) 27(42.2) 37(57.8)   
H. Pylori     
Positive 85(85.9) 91(96.8) 7.197 0.007* 
Negative 14(14.1) 3(3.2)   
t- Student t test for mean ages comparison, * P value is significant 
 
Table 2: Relationship between H. pylori positivity and demographic  
in Non-Diabetic subjects 
 






X2 P VALUE 
Age-group     
20-40 (n=7) 7(100.0) 2(0.0)   
41-60 (n=47) 46(97.9) 1(21.0) 1.113 0.573 
61-80(n=34) 32(94.1) 2(5.9)   
Gender     
Male (n=36) 34(94.4) 2(5.6) 1.055 0.304 
Female (n=58) 57(98.3) 1(1.7)   
Body mass index     
Underweight (n=6) 6(100) 0(0)   
Normal weight (n=21) 21(100) 0(0) 1.942 0.584 
Overweight (n=28) 26(92.9) 2(7.1)   
Obese (n=16) 15(93.8) 1(6.2)   
 
 
Table 3: Relationship between H.Pylori positivity and demographic and  
clinical parameters among diabetes 
 






X2 P value 
Age group     
20-40 (n=4) 4(100) 0(0) 0.765 0.682 
41-60 (n=50) 43(86.0) 7(14.0)   
61-90 (n=44) 37(84.1) 7(15.9)   
Sex     
Males (n=39) 29(74.4) 10(25.6) 7.009 0.008* 
Females (n=60) 56(93.3) 4(6.7)   
Medication     
OHA (n=62) 53(85.5) 9(14.5) 0.169 0.919 
OHA plus insulin (n=14) 12(85.7) 2(14.3)   
Insulin (n=1) 1(100) 0(0)   
Body mass index     
Underweight (n=3) 3(100) 0(0)   
Normal weight (n=18) 13(72.2) 5(27.8) 2.826 0.419 
Overweight (n=17) 15(88.2) 2(11.8)   
Obese (n=55) 46(83.6) 9(16.4)   
Duration of Diabetes     
Less than 1yr (n=8) 6(75.0) 2(25.0)   
1-5years (n=21) 18(85.7) 3(14.3) 0.548 0.908 
6-10years (n=14) 11(78.6) 3(21.4)   
>10years (n=16) 13(81.2) 3(18.8)   
Therapy across all groups is inclusive of dietary control, OHA- Oral hypoglycemic agent 
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